GlassScriptPhysician profile
Randall M Mccoy
NPI 1134616733
$3,081.25
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,793 · 2022: $263 · 2023: $739 · 2024: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,331.17 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Actelion Pharmaceuticals US, INC. | $477.29 | 2021-2024 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $259.13 | 2021-2023 | Farxiga |
| Alnylam Pharmaceuticals INC. | $161.99 | 2021-2023 | Onpattro |
| Zoll Respicardia, INC. | $156.34 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $134.94 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $115.57 | 2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.53 | 2021-2023 | Ofev |
| United Therapeutics Corporation | $65.20 | 2021 | |
| Heartflow, INC. | $58.59 | 2023 | Ffrct |
| Impulse Dynamics (USA) INC. | $54.59 | 2022 | |
| Novartis Pharmaceuticals Corporation | $50.71 | 2022-2023 | |
| Novo Nordisk INC | $47.05 | 2021-2022 | |
| Pfizer INC. | $36.45 | 2021 | |
| Merck Sharp & Dohme LLC | $34.40 | 2022-2023 | Verquvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.